1. Home
  2. KBSX vs RLYB Comparison

KBSX vs RLYB Comparison

Compare KBSX & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

HOLD

Current Price

$1.25

Market Cap

53.5M

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$9.07

Market Cap

43.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
RLYB
Founded
1976
2018
Country
Taiwan
United States
Employees
394
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
43.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KBSX
RLYB
Price
$1.25
$9.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
93.7K
54.6K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$858,000.00
Revenue This Year
$18.65
N/A
Revenue Next Year
$16.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.00
52 Week Low
$1.04
$0.27
52 Week High
$2.95
$11.49

Technical Indicators

Market Signals
Indicator
KBSX
RLYB
Relative Strength Index (RSI) 49.33 63.15
Support Level $1.08 $7.93
Resistance Level $1.42 $9.25
Average True Range (ATR) 0.09 0.31
MACD 0.00 0.02
Stochastic Oscillator 33.31 79.84

Price Performance

Historical Comparison
KBSX
RLYB

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: